Synthetically manufactured tetrahydrocannabinol (THC), sold under the brand names Marinol and Syndros, produced by Insys Therapeutics and Solvay Pharmaceuticals, marketed legally in the United States under Schedule III of the Controlled Substances Act, though natural THC is banned under Schedule I.

« Back to Glossary Index